Apr 03 2018
Surgical Products Magazine
In the wake of Auris receiving FDA clearance for its Monarch Platform, the innovative robotic technology is catching the attention of many. According to Surgical Products Magazine, the Monarch Platform’s approach to flexible technology with its application in bronchoscopy could be a game-changer. The article also mentions reasons why Auris Health CEO, Dr. Fred Moll, believes the technology has the potential to transform the treatment of lung cancer.
Excerpt from the article:
“…and the system combines the video from the endoscopic camera with 3D models of patient anatomy to provide computer-assisted navigation and an uninterrupted view of the entire procedure.”
“Moll insists the current FDA clearance is just the beginning, emphasizing the “Platform” in the new device’s name. The intent is for it to eventually be employed for a wide array of endoscopic procedures.”